Catalyst Wire Dossier Catalyst Wire Dossier

linagliptin/metformin fixed-dose combination tablet

linagliptin/metformin · Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for linagliptin/metformin fixed-dose combination tablet, covering 2013-08-20 to 2014-08-20. Get the full timeline:

Most recent: Clinical Trial Update: Bioequivalence of a Linagliptin / Metformin Fixed-dose Combination (FDC) Tablet Compared With Single Linagliptin and Metformin Tablets Administered Together in Healthy Volunteers [Phase 1]

See pricing